Volume 65, Issue 4 pp. 267-271

Incidence of chronic myeloproliferative disorders in the city of Göteborg, Sweden 1983–1992

Börje Ridell

Börje Ridell

Department of Pathology,

Search for more papers by this author
Jan Carneskog

Jan Carneskog

Department of Internal Medicine Sahlgrenska University Hospital, and

Search for more papers by this author
Hans Wedel

Hans Wedel

Nordic School of Public Health, Göteborg, Sweden

Search for more papers by this author
Lars Vilén

Lars Vilén

Department of Internal Medicine Sahlgrenska University Hospital, and

Search for more papers by this author
Inge Høgh Dufva

Inge Høgh Dufva

Department of Internal Medicine Sahlgrenska University Hospital, and

Search for more papers by this author
Ulf-Henrik Mellqvist

Ulf-Henrik Mellqvist

Department of Internal Medicine Sahlgrenska University Hospital, and

Search for more papers by this author
Niklas Brywe

Niklas Brywe

Department of Internal Medicine Sahlgrenska University Hospital, and

Search for more papers by this author
Hans Wadenvik

Hans Wadenvik

Department of Internal Medicine Sahlgrenska University Hospital, and

Search for more papers by this author
Jack Kutti

Jack Kutti

Department of Internal Medicine Sahlgrenska University Hospital, and

Search for more papers by this author
First published: 25 December 2001
Citations: 32
B. Ridell MD, Department of Pathology and Cytology, Sahlgrenska University Hospital, S 41345 Göteborg, Sweden
Tel: +46–31–3421995
Fax: +46–31–415792
e-mail: [email protected]

Abstract

Abstract: An estimation of the incidence of polycythaemia vera (PV), essential thrombocythaemia (ET) and chronic idiopathic myelofibrosis (CIM) in the city of Göteborg, Sweden during the period 1983–1992 was made from a retrospective case analysis of patients registered as chronic myeloproliferative disorders (CMPD) at the Departments of Medicine and the Department of Pathology of the two major hospitals in the city. A total of 125 cases of PV, 56 males and 69 females were identified. The number of cases as well as the age-specific incidence increased with age. The over all annual gender-specific incidence was 2.69 cases per 105 male inhabitants and 3.12 cases per 105 female inhabitants. The incidence of PV in relation to the European Standard Population was 2.02 cases per 105 inhabitants and year. There were 72 cases, 20 males and 52 females, with ET. The age-specific incidence was in all ages higher for females than for males and increased with age. The annual gender-specific incidence was 0.96 per 105 male inhabitants and 2.35 per 105 female inhabitants. The incidence of ET in relation to the European Standard Population was 1.28 per 105 persons and year. There were 20 cases of CIM, 11 males and 9 females. The annual gender-specific incidence of CIM was 0.53/105 male inhabitants and 0.41/105 female inhabitants. The incidence of CIM in relation to the European Standard Population was 0.31 per 105 persons and year. Seven persons, 2 males and 5 females, had a CMPD that could not be included in any of the above-mentioned groups, but were registered as CMPD, unclassified.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.